<p>Time to progression in non-muscle invasive bladder cancer according to <i>C16orf74</i> mRNA expression levels.</p
<p>BGN mRNA was investigated in 76 patients with bladder cancer by RT-qPCR and compared to non-malig...
BACKGROUND: Cell cycle proteins are important markers in predicting tumor behavior in urothelial car...
Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and cl...
expression level and progression in non-muscle invasive bladder cancer (NMIBC). mRNA levels were ex...
Purpose: Methylation-induced silencing of PRSS3 has been shown to be significantly associated with i...
PURPOSE: Methylation-induced silencing of PRSS3 has been shown to be significantly associated with i...
In bladder cancer, clinical grade and stage fail to capture outcome. We developed a clinically appli...
PURPOSE: Despite being one of the most important clinical outcomes in nonmuscle invasive bladder can...
Editorial Material; Comment on Prognostic Impact of a 12-gene Progression Score in Non-muscle-invas...
Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder can...
An estimated 9,000 Canadians are diagnosed with bladder cancer each year making it the 5th most comm...
We are in agreement with Lamm et al regarding the need for a new standard definition to describe pro...
Bladder cancer (BC) is one of the most expensive lifetime cancers to treat because of the high recur...
UnrestrictedUrothelial carcinoma of the urinary bladder is the seventh most common type of cancer wo...
Bladder cancer is associated with high recurrence and mortality rates. These tumors show vast hetero...
<p>BGN mRNA was investigated in 76 patients with bladder cancer by RT-qPCR and compared to non-malig...
BACKGROUND: Cell cycle proteins are important markers in predicting tumor behavior in urothelial car...
Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and cl...
expression level and progression in non-muscle invasive bladder cancer (NMIBC). mRNA levels were ex...
Purpose: Methylation-induced silencing of PRSS3 has been shown to be significantly associated with i...
PURPOSE: Methylation-induced silencing of PRSS3 has been shown to be significantly associated with i...
In bladder cancer, clinical grade and stage fail to capture outcome. We developed a clinically appli...
PURPOSE: Despite being one of the most important clinical outcomes in nonmuscle invasive bladder can...
Editorial Material; Comment on Prognostic Impact of a 12-gene Progression Score in Non-muscle-invas...
Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder can...
An estimated 9,000 Canadians are diagnosed with bladder cancer each year making it the 5th most comm...
We are in agreement with Lamm et al regarding the need for a new standard definition to describe pro...
Bladder cancer (BC) is one of the most expensive lifetime cancers to treat because of the high recur...
UnrestrictedUrothelial carcinoma of the urinary bladder is the seventh most common type of cancer wo...
Bladder cancer is associated with high recurrence and mortality rates. These tumors show vast hetero...
<p>BGN mRNA was investigated in 76 patients with bladder cancer by RT-qPCR and compared to non-malig...
BACKGROUND: Cell cycle proteins are important markers in predicting tumor behavior in urothelial car...
Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and cl...
DOI
Add to ORKG